2
Clinical Trials associated with Filgrastim biosimilar(Siam Bioscience Co. Ltd.)A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Filgrastim (Filgrastim/SBS) 300 mcg SC injection relative to Filgrastim (Filgrastim/CIM) 300 mcg SC injection
A Prospective Study on Efficacy and Safety of Filgrastim (Leuco-Plus 300) for Prevention of Chemotherapy Induced Neutropenia in Patients with Diffuse Large B-Cell Lymphoma
100 Clinical Results associated with Filgrastim biosimilar(Siam Bioscience Co. Ltd.)
100 Translational Medicine associated with Filgrastim biosimilar(Siam Bioscience Co. Ltd.)
100 Patents (Medical) associated with Filgrastim biosimilar(Siam Bioscience Co. Ltd.)
100 Deals associated with Filgrastim biosimilar(Siam Bioscience Co. Ltd.)